Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medihai (Beijing Medihai Data Technology Co., Ltd.) is a specialized healthcare technology company that provides real-world evidence (RWE) and digital clinical research solutions to the life sciences industry. Founded in 2016 and headquartered in Beijing, the company offers a comprehensive suite of digital tools, including Electronic Data Capture (EDC), Clinical Trial Management Systems (CTMS), and advanced data analytics platforms. Medihai focuses on bridging the gap between traditional clinical trials and real-world clinical practice by leveraging big data and artificial intelligence to generate high-quality evidence for drug development and regulatory decision-making. The company serves a diverse clientele, including global pharmaceutical enterprises, medical device manufacturers, and academic research institutions, helping them optimize research efficiency and product value demonstration. Medihai is recognized as a leader in the Chinese RWE market and actively contributes to the development of industry standards for medical data application.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maidihai.